Search

for
Search:

Glossary

Similar Terms

Saccharomyces cerevisiae

Learn

0 / 0 results

— no results

Research

5 / 1000+ results

research Quality of Life After Endovascular Repair Versus Open Surgery for Abdominal Aortic Aneurysms

June 2016 in “American Journal of Cardiology”

Endovascular repair and open surgery for abdominal aortic aneurysms both result in a temporary decline in physical health, with no significant mental health difference, and a return to near normal health in 90 days.

research Midterm Results Following Percutaneous Rotational Thrombectomy for Acute Occlusions of Arteriovenous Access Grafts

June 2016 in “American Journal of Cardiology”

The treatment successfully reopened blood flow in most patients and extended the use of their dialysis access with low risk.

research The Effect of a Food Supplement and a Hair Lotion on the Progression of Androgenetic Alopecia

2 citations, January 2019 in “Journal of Cosmetics, Dermatological Sciences and Applications”

The supplement and lotion significantly reduced hair loss and improved hair health.

research Influence of Genotype and Hyperandrogenism on Sexual Function in Women With Congenital Adrenal Hyperplasia

11 citations, August 2019 in “The Journal of Sexual Medicine”

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

research Simvastatin Reduces Autoimmune Alopecia Through Direct Action on T Lymphocytes

1 citations, April 2018 in “Journal of Investigative Dermatology”

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

View more "bayer" in research →

Community Join

5 / 56 results

community Bayer says drug research focus no longer on women´s health ( They dismissed HMI-115 because of their focus on women´s health

in Technology 4 upvotes 1 year ago

Hair loss treatments discussed include Minoxidil, Finasteride, and RU58841. Bayer dismissed HMI-115 due to focus shift away from women's health.

community HMI-115: What We Know So Far. HMI-115 (also known as BAY1158061) is a new pharmaceutical drug developed by a biopharmaceutical company called Bioinvent and licensed by Bayer

in Research/Science 51 upvotes 9 months ago

HMI-115 is a new drug developed by Bioinvent and licensed by Bayer, with mixed opinions on its potential effectiveness. Some users are skeptical and prefer proven treatments like Minoxidil, finasteride, and RU58841.

community does lowering your prolactin levels regrow hair?

in Research/Science 11 upvotes 2 years ago

The potential of lowering prolactin levels to regrow hair, with a reference to Bayer's drug HMI 115 which has been indicated as having this effect. Treatments mentioned include Minoxidil and Finasteride, as well as RU58841.

community Residents of Victoria, Australia, sign up for a monoclonal antibody clinical trial – potential cure

in Research/Science 2 years ago

A monoclonal antibody clinical trial for potential hair loss treatments in Victoria, Australia and the discussion of their efficacy. People shared information about similar drugs already on the market, speculated about potential side effects, and discussed how to spread the word about the trial.

community HLT Megathread on HMI-115 (key takeaways in comments)

in Research/Science 39 upvotes 2 years ago

HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

View more "bayer" in community →